ENT.L - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 20/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)

0.85x

Defensive

Volatility (5Y p.a.)

38.4% p.a.

5-Year Horizon

Max Drawdown (5Y)

-81.1%

5-Year Horizon

Sharpe Ratio

-0.78

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-48.7%
3 Years	39.3%	-59.8%	-0.64	-22.8%
5 Years	38.4%	-81.1%	-0.78	-27.6%
10 Years	41.1%	-82.7%	-0.2	-5.7%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 335%.

Unprofitable business model: The company is currently generating net losses.

🔴 High valuation risk: Avg P/E of 676.0 (Elevated multiple compression risk)

Strong cyclicality: The business model is sensitive to economic downturns.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -82.7% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

3 ISS Score: 3 / 10

Audit Risk

5 ISS Score: 5 / 10

Board Risk

4 ISS Score: 4 / 10

Short Ratio